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Abstract
Rationale A sensitized dopamine system may be linked to
the genesis of psychotic symptoms in schizophrenia.
Following withdrawal from amphetamine exposures,
psychotic-like traits have been robustly demonstrated, but
the presence of cognitive/mnemonic deficits remains
uncertain.
Methods Adult male Lewis and Fischer rats, differing in
cognitive performance, were exposed intermittently to
escalating doses of amphetamine over 5 weeks. This was
effective in producing behavioral sensitization to a
subsequent amphetamine challenge. Following 27 days
of drug withdrawal, the animals were assessed in Pavlov-
ian conditioning, object recognition, and spatial working
memory. In addition, prepulse inhibition (PPI), spontane-
ous motor activity, and anxiety-like behavior were
measured.
Results Amphetamine pretreatment induced behavioral
sensitization in both rat strains similarly. Working memory
was enhanced in Fischer but not Lewis rats following
withdrawal. Spontaneous novel object preference was
enhanced in sensitized Fischer rats, but was impaired in
sensitized Lewis rats, thus effectively reversing the strain
difference in non-sensitized controls. In contrast, Pavlovian
fear conditioning remained unaffected and so were anxiety-
like behavior, open field activity, and PPI.
Conclusion The face validity of the amphetamine with-
drawal model for cognitive deficits was limited to the
object recognition memory impairment observed in sensi-
tized Lewis rats. Yet, the possibility that enhancing
dopaminergic neurotransmission may facilitate object rec-
ognition and spatial working memory performance was
demonstrated in sensitized Fischer rats. Identification of the
mechanisms underlying such strain-dependent effects would
be instrumental in the further specifications of the construct
validity, and therefore the limitations and potential of the
amphetamine sensitization model of schizophrenia.
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Introduction
Pharmacological sensitization refers to the enhancement or
intensification of the specific response to a drug following
prior exposure to the same (or functionally similar) drug.
Sensitization of the motor responses to systemic amphet-
amine—a dopamine releaser—has been very well docu-
mented in rodents (for review, see Robinson and Becker
1986), and it has been studied in the context of drug
addiction and schizophrenia (Kalivas et al. 1993; Nestler
2001; Robinson and Becker 1986). Support for its construct
validity as a potential animal model for some aspects of
schizophrenia includes recent neuroimaging reports which
demonstrate enhanced striatal dopamine release induced by
an acute amphetamine challenge in first-episode schizo-
phrenia patients relative to healthy controls (Abi-Dargham
et al. 1998; Breier et al. 1997; Laruelle 2000). It is further
linked to an overexpression of mesolimbic dopamine D2
receptors in the patients (Abi-Dargham et al. 2000; Laruelle
1998; Wong et al. 1986). These findings have led to the
“endogenous sensitization” hypothesis of schizophrenia,
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which postulates that a sensitized dopamine system is
intrinsic to the disease and is responsible for the genesis of
psychotic symptoms (Abi-Dargham et al. 1998; Breier et al.
1997; Laruelle 2000; Lieberman et al. 1997).
Repeated systemic amphetamine administrations in
rodents not only result in an enduring sensitized response
to a subsequent amphetamine challenge, they are also
associated with changes in brain and behavior that are
particularly pronounced following a prolonged period of
abstinence or withdrawal (Paulson et al. 1991). The
withdrawal period thus represents a drug-free but altered
brain state that may better mimic the situations in
schizophrenia patients than the use of acute amphetamine
treatment in animals. Studies of amphetamine withdrawal
have yielded evidence for the presence of behavioral
dysfunctions relevant to schizophrenia in the absence of
further drug challenge, including deficits in latent inhibition
(LI) and prepulse inhibition (PPI) (Peleg-Raibstein et al.
2008; Peleg-Raibstein et al. 2006a; Peleg-Raibstein et al.
2006b; Russig et al. 2005; Tenn et al. 2003). LI and PPI
deficits have been reported in schizophrenia patients and
have been linked to an underlying impairment in selective
attention and sensorimotor gating, respectively (Feldon and
Weiner 1992; Geyer et al. 2001; Gray et al. 1991;
Swerdlow et al. 2000).
The amphetamine withdrawal state is also associated
with a variety of behavioral, molecular, neuroanatomical,
and neurochemical adaptations in rodents and primates
beyond the striatal dopaminergic system (Castner et al.
2005; Fletcher et al. 2005; Kolb et al. 2003; Peleg-Raibstein
et al. 2008; Sokolov et al. 2003; Wolf 2003), suggesting that
its application may extend beyond the modeling of dopami-
nergic dysfunction that is more closely linked to the
psychotic symptoms of the disease. Schizophrenic patients
also suffer from a variety of cognitive impairments,
including deficits in working memory (Goldman-Rakic
1994; Weinberger and Gallhofer 1997), episodic memory,
attention, cognitive flexibility, and executive functioning
(Elvevag and Goldberg 2000; Gold et al. 1997; Goldberg et
al. 1987, 1998; Pantelis et al. 1999; Pantelis et al. 2004).
Indeed, the persistence and resistance to medication of such
cognitive symptoms has been recognized as a major barrier
impeding the effective social rehabilitation of schizophrenia
patients (Braff and Light 2004; Green and Nuechterlein
1999).
Attempts to identify the presence of such cognitive and
information processing deficits during amphetamine with-
drawal in rats have yielded somewhat mixed but still
encouraging outcomes. Two studies have thus far failed to
show any clear changes in working memory function in
animals undergoing amphetamine withdrawal (Featherstone
et al. 2008; Stefani and Moghaddam 2002), while one study
showed that amphetamine sensitization led to enhanced
reversal in spatial learning in the water maze (Russig et al.
2003), which may instead be suggestive of a possible
enhancing effect in working memory. The finding of Russig
et al. (2003) is in keeping with the finding in LI (see
above), but disagrees with reports of impairment in
attentional set shifting (Featherstone et al. 2008; Fletcher
et al. 2005) and visual attention (Fletcher et al. 2007).
Clarification of the face validity of the amphetamine
withdrawal models with respect to cognitive symptoms is
therefore warranted, given the increasing clinical awareness
of this symptom category (Green 2006; Green and
Nuechterlein 1999).
Amphetamine-induced behavioral modification can vary
considerably between strains (e.g., Alexander et al. 1996).
Here, we examined the impacts of amphetamine withdrawal
on cognitive function in a comparison between Fischer 344
and Lewis rats because their behavioral and neurochemical
responses to drugs of abuse are known to markedly differ
(for a review, see Kosten and Ambrosio 2002), suggesting a
difference in dopaminergic function that may lead to
divergent outcomes following repeated amphetamine pre-
treatment. In particular, the marked differences in cognitive
and executive functions documented between these two rat
strains (Pryce et al. 1999; Stohr et al. 1998b, 2000; van der
Staay and Blokland 1996) fit our present focus on the
cognitive impacts following amphetamine withdrawal. To
this end, we conducted here various mnemonic tests,
assessing associative learning, object recognition memory,
and water maze learning. The relatively poor performance
in these tests expected in Fischer rats would also facilitate
the detection of any possible performance-enhancing effect
of amphetamine withdrawal. Such possibility could be
indicated by amphetamine-induced enhancement in work-
ing memory similar to the effects seen in Russig et al.
(2003). In addition, tests of anxiety-related traits and
spontaneous open field locomotor/explorative activity were
conducted to identify possible confounds in data interpre-
tation. In view of the suggestion that PPI disruption may
provide an index of cognitive deterioration in schizophrenia
patients (Geyer 2006), we also evaluated PPI here. The
specific escalating amphetamine regimen (intermittent
escalating doses from 1 to 5 mg across 5 weeks) adopted
here originates from Fletcher and colleagues, who reported
its efficacy produce PPI disruption as well as some
cognitive deficits in Sprague–Dawley rats (Featherstone et
al. 2008; Fletcher et al. 2005; Tenn et al. 2003), which may
be more effective than the escalating amphetamine regime
(escalating doses from 1 to 5 mg across 6 days) examined
by us (Murphy et al. 2001; Peleg-Raibstein et al. 2006a;
Russig et al. 2002, 2003, 2005). At the end of the study,
behavioral sensitization to the motor stimulant effect of a
subsequent amphetamine challenge was confirmed in a
subset of animals from both strains.
604 Psychopharmacology (2009) 206:603–621
Materials and methods
Subjects
Naive male adult Fischer (F344/NHsd) and Lewis (LEW/
HANRijHsd) rats obtained from Harlan (Borchen,
Germany) were first acclimatized to our laboratory housing
facilities for 2 weeks before drug treatment began. The rats
were housed individually under a reversed light–dark cycle
(lights on 1900–0700 h) with controlled temperature (21±
1°C) and humidity (55±5%) conditions. Access to food and
water was provided ad libitum throughout the entire
experiment, with all tests carried out in the dark phase of
the cycle. Rats were handled daily for 5 days prior to
amphetamine pretreatment. Following the final amphet-
amine/saline pretreatment injection, all subjects were left
completely undisturbed in their home cages until the
commencement of behavioral evaluation on withdrawal
day 27. The animals were subjected to multiple behavioral
tests as detailed in Fig. 1. However, only a random half of
the subjects in each treatment condition underwent the
fear conditioning test, and in a further random selection
(balanced across treatment conditions), 16 subjects were
evaluated for the expression of behavioral sensitization to
amphetamine. All procedures carried out on the animals
had been previously approved by the Zurich Cantonal
Veterinary Office, in accordance with the Animal Protec-
tion Act of Switzerland (1978), the European Council
Directives 86/609/EEC on animal experimentation (1986),
and the Principles of Laboratory Animal Care (NIH
publication No. 86-23, revised 1985).
Drugs and pretreatment
D-Amphetamine sulfate (Sigma Chemical Company, St.
Louis, USA) was dissolved in a 0.9% NaCl solution to
obtain the required concentrations of 1–5 mg/ml. All the
solutions were freshly prepared and administered in a
volume of 1 ml/kg via the intraperitoneal route. The rats
were randomly assigned to either the saline or amphetamine
group and received accordingly either one amphetamine or
one saline injection on 3 days per week (Monday,
Wednesday, and Friday) for five consecutive weeks. The
doses of amphetamine were increased from 1 to 5 mg/kg, in
increments of +1 mg/kg every week. Immediately after the
injection, each rat was returned to its home cage.
Elevated plus maze test of anxiety
On withdrawal day 27, the rats were tested in the elevated
plus maze as previously described (Russig et al. 2005). The
test lasted 5 min and began with a rat being placed on the
central platform, the head facing an open arm. An
Ethovision tracking system (Version 3.1, Noldus Technol-
ogy, The Netherlands) calculated the total distance moved
and the time spent in each arm. The distance moved was
used as an index of locomotion; the ratio of time spent in
the open arms to total time spent in all four arms was used
Fig. 1 Schematic illustration of the sequence of the behavioral tests
performed. The behavioral test schedule, with exact withdrawal days
and number of animals used per strain (Fischer and Lewis) and per
pretreatment (amphetamine and saline). Gray box indicates a
manipulation free period; the animals were left undisturbed in their
home cages. Black box indicates the specific test the animals
underwent. The fear conditioning experiment was originally planned
to run as two replications. Given that the first cohort (with half of the
subjects) was sufficient to generate a clear outcome, we refrained from
further testing of the second cohort on ethical grounds. In order to
complete the behavioral sensitization experiment on precisely the
same withdrawal day, only a balanced cohort of 16 animals was
evaluated, this being the maximum capacity of our long-term
locomotor activity monitor system
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as an index of anxiety. The maze was cleaned with ethanol
15% and allowed to dry after each trial.
Open field test of spontaneous locomotor activity
and explorative behavior
This was conducted on withdrawal day 28 using four
identical gray acrylic open field arenas as fully described
elsewhere (Stohr et al. 1998b). The distance traversed in the
arena was measured using the Ethovision tracking system.
Each trial lasted for 30 min and began with an animal being
placed in the center of each arena. The subjects were tested
in squads of four, with pretreatment and strain counter-
balanced across the four open field arenas. These were
cleaned with ethanol 15% and allowed to dry after each test.
Pavlovian conditioned freezing
This began on withdrawal day 32, using two sets of four
Coulbourn operant conditioning chambers (Coulbourn
Instruments, Allentown, PA, USA), which have previously
been described in full (Richmond et al. 1998). Each
chamber was housed inside a ventilated and sound-
attenuated chest. One set (context A) was used for
conditioning and test of conditioned context freezing and
was equipped with a shock-administering grid floor (Model
no. E10-10RF) in each chamber. The other set (context B)
was used for test of conditioned tone freezing. The two sets
of context differed in terms of the grid mesh design (A:
bars, B: round holes), the shape of the Plexiglas enclosure
(A: square B: round), and the level of illumination (A: dim
light, B: infrared light).
Stimulus presentation was controlled by a Coulbourn
Universal Environment Interface (model no. E91-12) and a
Coulbourn Universal Environment Port (model no. L91-12).
The discrete stimulus used was an 86-dBA tone produced by
a 2.9-kHz tone module (model E12-02) fixed in the wall of
each test chamber, with indistinguishable acoustic charac-
teristics between the two contexts. Shocks were delivered
using a Coulbourn Precision Animal Shocker (model no.
E13-12). During all testing sessions, background noise of
48 dBA was provided by a ventilation fan fixed to the outer
chest of each chamber.
Aminiature infrared-sensitive digital camera with a 2.5-mm
wide angle (100°) lens (CES AG, Zurich, Switzerland, VPC-
465B) and two infrared emitting diodes (Hewlett-Packard,
Palo Alto, CA, USA; model no. HSDL-4220) were installed in
each chamber. The cameras captured images at 1 Hz for
transmission to a PC for image analysis and quantification
of freezing. Comparison between successive frames taken at
1 s apart was performed according to the algorithm
described by Richmond et al. (1998) and implemented on
a PC running the WiT (version 5.3, DALSA, Waterloo,
Ontario, Canada) image analysis program controlled by a
visual basic macro program prepared in-house (Peter
Schmid). The number of pixels changed (defined as a change
in brightness over 8%) between successive frames was
calculated. Freezing for the given 1-s interval was scored
when the total number of pixels changed was less than 0.05%
of the total pixels.
The experiment began with 1 day of apparatus habitu-
ation (context A), followed by conditioning, a context test,
and a tone test, at 24 h intervals. On the conditioning day,
all animals underwent ten trials of tone–shock pairings,
administered at a fixed inter-trials interval (ITI) of 2 min.
Each conditioning trial began with a 9-s tone followed
immediately by a 1-s foot shock set at 0.5 mA. On the next
day (context test), the animals were returned to the shocked
context (context A) and left undisturbed for 8 min. On the
last day, test of conditioned freezing to the tone was
conducted in a novel context (context B), in which the
animals were first left undisturbed in the apparatus for
3 min (pre-CS period) before the onset of the tone CS that
remained on for 8 min (CS period).
Prepulse inhibition
The evaluation of PPI of the acoustic startle reflex was
conducted on withdrawal days 38 and 39. The apparatus
consisted of four sound-attenuated acoustic startle chambers
(SR-LAB; San Diego Instruments, San Diego, CA, USA)
as fully described before (Pothuizen et al. 2006). A constant
68-dBA background noise was presented throughout the test
session. Three different pulse intensities (at 100, 110, and
120 dBA), 30 ms in duration, and three different prepulse
intensities (at 74, 80, and 86 dBA), which corresponded
to +6, +12, and +18 dB above background, respectively,
20 ms in duration were used. These allowed nine possible
prepulse-and-pulse combinations. A stimulus onset asyn-
chrony (SOA) of 100 ms between the two stimuli on
prepulse-and-pulse trials was used throughout. In addition
to the analysis of the reactivity score (following logarithmic
transformation), PPI was also expressed as percent inhibi-
tion at each prepulse intensity by: %PPI = [(pulse-alone −
prepulse-and-pulse)/pulse-alone × 100%]. Testing was
completed in 2 days, with all between-subject factors fully
counterbalanced across days and boxes.
Object recognition
This test was conducted on withdrawal days 48 and 49
using one of the open field arenas described above in a
dimly lit testing room (15 lx). A video camera was mounted
above the arena to allow digital recording of the session for
subsequent data extraction. The test comprised two phases,
sample phase and test phase, which were separated by one
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of two different retention intervals (2 min or 15 min,
conducted on separate days). To begin the sample phase,
two identical objects were placed at the two opposing
corners (15 cm clear of the walls), and the subject was
introduced to the arena center with its head facing one of
the empty corners chosen at random. This phase lasted for
5 min and was followed by the retention interval. Next, the
test phase began with one new copy of the sample
(familiar) object placed in one of the two previously
occupied corners and a copy of a novel object discrim-
inandum (new) in the opposing corner. The relative
placement of the novel and familiar objects was counter-
balanced between subjects. The arena and objects were
cleansed with 15% ethanol prior to each phase.
Four distinct objects, with three copies of each, were used
as discriminanda for the experiment. They were: (a) brown
plastic flower pots (average diameter 30 cm, height 17.5 cm),
(b) white plastic boxes (13.5×8.5×9 cm), (c) transparent
glass bottles (diameter 9.5 cm, height 20 cm), and (d) red
bricks (14×9.7×28.3 cm). They were used as two fixed
pairs: (a) vs. (b) and (c) vs. (d); one pair was used uniquely
for each test day. The two test days differed in the delay
interval between sample and test runs. The order of, and the
combinations between, object pairs and delays were counter-
balanced across the 2 days of testing within each group.
Because rodents have a natural preference for novel
stimuli, the relative exploration time of the novel in
comparison to the familiar discriminanda was used to index
object recognition memory in the test phase. Exploration time
was extracted by an experimenter under blind conditions with
the assistance of the Observer software implemented on a
handheld PSION computer (Workabout, London, UK).
Water maze test of spatial working memory
The water maze experiment was conducted on withdrawal
days 50–55. The apparatus consisted of a circular fiberglass
tank, painted black, measuring 2 m in diameter by 60 cm
high, and positioned 40 cm above the floor in the middle of
a well-lit testing room with several distal cues fixed on the
room walls. It was filled with a mixture of fresh hot and
cold tap water every day to a depth of 30 cm and
maintained at 21±1°C. A rough circular platform (diameter
11 cm) submerged 2 cm below the water surface served as
the escape platform. A visual cue (circular white disk) could
be mounted 11 cm above it, to provide a local cue for the
platform location. A video camera was mounted directly
above the maze and connected to a PC running the
Ethovision® tracking system (Noldus Information Technol-
ogy, Wageningen, The Netherlands). Four equally spaced
points along the circumference of the maze were arbitrarily
assigned as N, E, S, and W, to define four equal quadrants
and different start locations.
On day 1, the animals were trained on a visually guided task
in two trials in which the platform was located in the middle of
the maze and marked by the local cue. To begin each trial, the
animals were released from the starting point and allowed 90 s
within which to escape onto the platform. If a rat failed to
locate the platform, it was guided to it by the experimenter.
The starting points for the two trials were always 180° apart:
either N and S, or E and W, with these two possibilities
counterbalanced with respect to all between-subject factors.
The working memory test took place over the next
5 days, with two test sessions conducted on each day,
separated by 4 h during which the rats were returned to
their home cage. The platform location was switched
between sessions, but remained unchanged across the two
trials of a given session. Eight possible platform positions
were defined (50 cm off the wall in each of the directions
N, NE, E, SE, S, SW, W, and NW), and each position was
used once in the first eight sessions, before the first two
locations were repeated on the last day. The different
platform locations were counterbalanced across all
between-subjects factors in each session. Trials 1 and 2 in
a session were separated by a delay of 30 s (including 15 s
spent on the platform), and working memory was indexed
by improvement between the two trials. A total of eight
possible starting positions were defined: N, E, S, W, NE,
SE, SW, and NW, and across the two trials of a given
session, the two starting positions were pseudorandomly
chosen from the five possible starting positions furthest
from the platform, with the condition that they must be at
least 90° apart.
Activity measurement for assessment of locomotor
sensitization
The apparatus consisted of 16 chambers (25×40×40 cm)
specially designed for long-term assessment of locomotor
activity, which was measured by an image analysis algo-
rithm as specified before. Activity scores were quantified
into successive 20-min bins. Full details of the apparatus and
hardware have been fully described in Russig et al. (2002).
The subjects were moved to the apparatus at 1740 h on
withdrawal day 57. At 0940 h on withdrawal day 58, a
saline injection was given, and 1 h later, an amphetamine
challenge (1 mg/kg, i.p.) was administered. The animals
were observed for another 3 h before being removed from
the chambers. The last hour before saline injection was
taken as the baseline period, for comparison with the saline
period (1 h) and the subsequent amphetamine period (3 h).
Statistical analysis
All statistical analyses were carried out using SPSS® for
Windows™ (version 13). Parametric analyses of variance
Psychopharmacology (2009) 206:603–621 607
(ANOVAs) of a split-plot (mixed) design consisting of the
two following between-subject factors: strain and pretreat-
ment, and appropriate within-subject factors as required by
the data set in question (e.g., time bins, trials, objects, pulse
and prepulse intensity, etc). Data interpretation was further
assisted by the use of restricted ANOVAs for determining
the locus of significant effects. The logarithmic transfor-
mation was applied to better conform to the normality
assumption of parametric ANOVA whenever appropriate:
PPI experiment (in pulse-alone, prepulse-alone and
prepulse-and-pulse trials), water maze (path length and
latency to reach the platform), and object recognition (time
spent exploring the object).
Results
Elevated plus maze
On withdrawal day 27, the animals were subjected to a test
of anxiety using the elevated plus maze. There was no
evidence for any significant strain difference or amphet-
amine pretreatment effect in anxiety-like behavior based on
a 2×2 (strain × pretreatment) ANOVA of percent time spent
in open arms (see Table 1). The interaction term also did
not attain statistical significance [F<1]. The two strains
also did not differ significantly in terms of locomotor
activity, as indexed by total distance moved in the entire
maze area (see Table 1). Amphetamine pretreatment had
yielded a slight reduction in this measure that was similarly
present in both strains. A separate ANOVA of total distance
moved yielded no significant effect, although the main
effect of pretreatment was close to statistical significance [F
(1, 44)=3.53, p=0.067]. Again, the interaction term was far
from statistical significance [F<1].
Open field
On withdrawal day 28, the open field was used to assess
spontaneous locomotor activity and spatial exploration.
There was a clear habituation effect of locomotor activity as
evidenced by a reduction in distance moved across
successive 5-min bins over the course of the 30-min test
period, which was observed in both strains (Fig. 2).
However, the two strains differed from each other at the
beginning of the test when Lewis rats appeared to be more
active. By the end of the test period, the activity levels of
both Fischer and Lewis rats had reduced to a similar
asymptotic level. These impressions were supported by a
2×2×6 (strain × pretreatment × bins) split-plot ANOVA of
distance traveled, which yielded a main effect of bins [F(5,
220)=61.14, p<0.001] and its interaction with strain [F(5,
220)=4.52, p<0.001], without the main effect of strain
achieving statistical significance. Pair-wise comparisons
between strains at successive bins only yielded signifi-
cant differences in the first two bins [p<0.05]. Amphet-
amine pretreatment, on the other hand, did not appear to
alter the overall activity level or the habitation of activity
over time. Neither the main effect of pretreatment [F(1,
Table 1 Elevated plus maze (EPM) indexes of anxiety and locomotor activity
EPM dependent variables Fischer Lewis
Amphetamine (n=12) Saline (n=12) Amphetamine (n=12) Saline (n=12)
Percent time in open arms 28.2±6.6 20.4±4.2 20.5±3.8 21.2±3.1
Total distance traveled (m) 14.9±1.1 16.8±0.8 13.3±1.0 15.2±1.1
Percentage time spent in the open arms (time in open arms/time in all four arms×100) was taken as an index of anxiety. Total distance moved was
taken as an index of locomotor activity. Mean values are presented separately for strain and pretreatment with the standard error of the mean. The
standard error for difference between means (SED) was 4.6 for the percentage time in open arms and 1.0 for total distance traveled.
Fig. 2 Locomotor activity in the open field. Locomotor activity in the
open field after 28 days of withdrawal in Fischer and Lewis rats
pretreated with saline or amphetamine (N=12 per strain per
pretreatment). The distance moved during the six 5-min bins (a) split
by strain and (b) split by amphetamine pretreatment and strain.
Locomotor habituation was observed in all subjects. An increased
locomotor activity was observed in Lewis in the two first 5-min bins.
All values are mean ± standard error derived from the ANOVA.
Asterisks refer to statistically significant differences between strains
(p<0.05) based on pair-wise comparisons performed on successive
bins using the appropriate error variance associated with the
significant strain × bins interaction in the overall ANOVA
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44)=1.27, p<0.27] nor its interactions [F’s<1] attained
statistical significance (data not shown).
Conditioned freezing
The conditioning day, context freezing test, and tone
freezing test (conducted on withdrawal days 32, 33, and
34, respectively) were separately analyzed. Within the
conditioning day, freezing measures obtained in the CS
and ITI periods were also separately analyzed.
Conditioning First, freezing response in the presence of the
tone was assessed across the ten trials of tone–shock
pairings (Fig. 3a). There was a rapid rise in freezing
following the first CS presentation when freezing was
almost absent. By the third presentation of the CS, response
in both strains had reached a peak, and a clear strain
difference emerged at the same time: Fischer rats exhibited
a substantially lower level of freezing which lasted till the
end of the session. These impressions were supported by a
2×2×10 (strain × pretreatment × trials) split-plot ANOVA
of percent time freezing which yielded a main effect of
trials [F(9, 396)=11.78, p<0.001], strain [F(1, 44)=18.41,
p<0.001], and their interaction [F(9, 396)=2.45, p<0.01].
Pair-wise comparisons between strains on successive trials
indicated that the two strains differed significantly from the
third trial onwards. Neither the factor pretreatment nor its
interaction reached statistical significance, which is consis-
tent with the impression that amphetamine pretreatment did
not alter the overall freezing behavior or its development
across trials (data not shown).
A highly similar pattern emerged from the freezing
measures obtained in the ITI periods (Fig. 3b). There was a
rapid rise in freezing from the beginning of the session,
followed by the emergence of a strain difference in the
same direction as described above. A 2×2×11 (strain ×
pretreatment × ITI) split-plot ANOVA of percent time
freezing per ITI period again yielded a main effect of ITI [F
(10, 200)=7.05, p<0.001], strain [F(31, 20)=31.40, p<
0.001], and their interaction [F(10, 200)=2.75, p<0.005].
Fig. 3 Percentage time freezing during conditioning, context freezing,
and tone freezing. Percentage time freezing in a Pavlovian tone–shock
conditioning experiment after 32–34 days of withdrawal in Fischer
and Lewis rats pretreated with saline or amphetamine (N=6 per strain
per pretreatment). Percentage time freezing split by strain during: a the
ten 9-s tone (CS) in the conditioning day (withdrawal day 32), b
during the eleven 2-min ITIs (withdrawal day 32), c during the eight
1-min bin of context freezing (withdrawal day 33), and d during the
three 1-min bins preceding the CS onset and the eight 1-min bins of
CS presentation of tone freezing (withdrawal day 34). e–h The same
percentage time freezing but split by pretreatment by strain. Lewis rats
showed an increased freezing in the conditioning day both during the
tone CS (from the third trial) and during the ITI (from the second
trial), in context freezing (throughout the 8 min) and in the tone
freezing (throughout the 8 min of CS exposure). In the tone freezing,
Lewis rats further presented extinction over time, which was not
observed in Fischer rats. All values are mean ± standard error derived
from the ANOVA. Asterisks in (a), (b), (c), and (d) denote the
significant (*p<0.05, ***p<0.001) main effect of strain based on pair-
wise comparisons performed on successive trials using the appropriate
error variance associated with the significant strain × trials interaction
in the overall ANOVA
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Pair-wise comparisons between strains at successive ITIs
showed that the strain difference was significant from the
second ITI onwards [all p’s<0.05]. Again, amphetamine
pretreatment was without any significant impact on this
measure (data not shown).
Context freezing On the next day, the animals were returned
to the shocked context and freezing behavior was evaluated
for 8 min in the absence of any discrete stimulus. The two rat
strains again differed similarly, with Fischer rats exhibiting
low levels of freezing compared to Lewis rats throughout the
8-min test period (Fig. 3b). This led to the emergence of a
highly significant strain effect [F(1, 44)=52.97, p<0.001]
from a 2×2×8 (strain × pretreatment × 1-min bins) split-
plot ANOVA of percent time freezing. The levels of
freezing also varied significantly across bins, yielding
therefore also a significant effect of bins [F(7, 308)=
30.90, p<0.001]. Pretreatment on the other hand had no
significant impact on freezing behavior observed on this
day; neither the main effect of pretreatment nor its
interaction was close to statistical significance [all F’s<1].
Tone freezing Baseline freezing behavior over the 3 min
prior to the tone onset was generally low, and as expected, a
2×2×3 (strain × pretreatment × 1-min bins) split-plot
ANOVA yielded no significant effect. During the presenta-
tion of the tone in the following 8 min, Fischer rats again
exhibited reduced freezing. This strain effect was sustained
over the entire 8-min CS period (Fig. 3c). These impres-
sions were supported by a 2×2×8 (strain × pretreatment ×
bins) split-plot ANOVA of percentage time freezing, which
yielded a significant main effect of strain [F(1, 20)=38.71,
p<0.001], bins [F(7, 140)=2.89, p<0.01], as well as their
interaction [F(7, 140)=3.06, p<0.05]. The interaction
stemmed from the presence of an initial increase followed
by an extinction profile over time in the Lewis but not in
the Fischer rats. Supplementary analyses restricted to either
strain confirmed this interpretation because a main effect of
bins was only revealed in the Lewis strain [F(7, 70)=4.66;
p<0.001]. Consistent with the previous days, pretreatment
had no significant impact on freezing behavior on this day:
neither the main effect of pretreatment nor its interaction
achieved statistical significance [all p’s>0.1].
Prepulse inhibition
Prepulse inhibition expression was assessed on withdrawal
day 38 or 39. Five separate analyses were conducted to
examine different aspects of performance in the PPI test.
Startle habituation Startle habituation was measured as the
diminution of the startle response between the first and last
block of trials that comprised only six pulse-alone trials
(two trials per pulse intensity per block). A general
habituation effect was detected in all groups and across all
three pulse intensity levels. As expected, the startle reaction
was proportional to the intensity of the pulse stimulus. The
mean ± standard error (SE) startle reaction (logarithmically
transformed) across all subjects in the first and last blocks, at
the three pulse intensities were as follows: 100 dBA: first =
3.69±.14, last=3.06±0.15; 110 dBA: first = 4.88±0.10, last =
4.44±0.13; and 120 dBA: first = 5.39±0.11, last = 4.94±0.13.
Neither strain nor pretreatment produced any significant
effect on this measure (data not shown). A 2×2×2×3
(strain × pretreatment × blocks × pulse intensity) split-plot
ANOVA of startle reactivity only revealed a significant
main effect of blocks [F(2, 8)=187.16, p<0.001], and of
pulse intensity [F(1, 44)=19.05, p<0.001]. There was no
significant main effect or interaction involving strain or
pretreatment [all p’s>0.1].
Startle reactivity on pulse-alone trials It is essential to
evaluate first the magnitude of the baseline acoustic startle
response obtained on pulse-alone trials in the main middle
blocks of the test session prior to the assessment of prepulse
inhibition. In agreement with the startle habituation analysis
described above, a 2×2×3 (strain × pretreatment × pulse
intensity) split-plot ANOVA of the reactivity score (loga-
rithmically transformed) did not reveal any differences in
pulse-alone trials due to either strain or pretreatment, but
only a significant main effect of pulse intensity [F(2, 88)=
369.70, p<0.001]. As expected, the startle response
magnitude increased as a function of pulse intensity
(Fig. 4d, +0 dBA prepulse intensity).
Percent PPI PPI refers to the attenuation of the startle
response to a pulse stimulus when it is preceded by a
prepulse. Given that acoustic startle response obtained on
pulse-alone trials did not differ between strains or between
pretreatment conditions, we first conducted an evaluation
based on the conventional measure of PPI using percent
inhibition: [%PPI = (pulse-alone − prepulse-and-pulse)/
(pulse-alone × 100%)]. This was calculated for each of the
nine possible prepulse-and-pulse combinations. As shown
in Fig. 4a, increasing prepulse intensity led to strong %PPI
in both Fischer and Lewis rats, with the Fischer rats
showing a consistently weaker %PPI. On the other hand,
pretreatment did not lead to any appreciable differences in
this measure of %PPI (Fig. 4b). These impressions were
confirmed by a 2×2×3×3 (strain × pretreatment × prepulse
intensity × pulse intensity) split-plot ANOVA of %PPI,
which yielded a significant main effect of prepulse intensity
[F(2, 88)=178.93, p<0.001] and of strain [F(1, 44)=12.04,
p<0.005]. The strain by pulse intensity interaction also
achieved statistical significance [F(2, 88)=3.45, p<0.05],
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suggesting that the strain difference in %PPI was more
pronounced with increasing pulse intensity. Separate anal-
yses restricted to each pulse intensity showed that the main
effect of strain achieved statistical significance only at pulse
intensities of 110 dB [F(1, 44)=6.46, p<0.05] and 120 dB
[F(1, 44)=23.16, p<0.001]. None of the analyses described
revealed any significant effects of pretreatment or its
interaction (Fig. 4c).
Prepulse-and-pulse trials reactivity The above impression
of a pulse-dependent reduction of PPI expression in the
Fischer relative to Lewis rats was confirmed by the analysis
based on the startle reactivity magnitude obtained on pulse-
alone and prepulse-and-pulse trials. In this analysis, the
magnitude of PPI is reflected by the slope of the individual
reactivity curves depicted in Fig. 4d and e. It can readily be
seen that reactivity reduced with increasing prepulse
intensity, regardless of pulse intensity and strains. The
response to the presence of the prepulse stimulus was,
however, weaker in the Fischer rats, as most obviously seen
at the highest pulse intensity condition (pulse=120 dB),
supporting the impression of a pulse intensity-dependent
reduction of PPI in the Fischer rats identified in the %PPI
analysis above. This is confirmed by the presence of the
critical strain × prepulse intensity × pulse intensity
interaction [F(6, 264)=3.31, p<0.005] in a 2×2×4×3
(strain × pretreatment × prepulse intensity × pulse intensity)
split-plot ANOVA of startle reactivity (logarithmically
transformed) across all pulse-alone and prepulse-and-pulse
trials. Consistent with this interpretation, strain by prepulse
intensity interaction ([F(3, 132)=12.24, p<0.001] as well
as a strain by pulse intensity interaction [F(2, 88)=15.57,
p<0.001] also attained statistical significance. Restricted
analysis applied to each pulse intensity condition revealed
the presence of a strain by prepulse intensity interaction only
in the conditions of pulse=110 dB [F(3, 132)=3.17, p<0.05]
and of pulse=120 dB [F(3, 132)=16.22, p<0.001], but not
at the lowest pulse intensity, thereby confirming the pulse-
dependent strain difference in the expression of PPI. Again,
none of the analyses described revealed any significant
effects of pretreatment or its interaction (Fig. 4e).
Direct reaction in prepulse-alone trials To examine the
direct reaction elicited by the prepulse stimulus alone, the
reactivity scores (logarithmically transformed) obtained in
prepulse-alone trials as well as in no-stimulus trials were
Fig. 4 Prepulse inhibition of the startle reactivity. Prepulse inhibition,
expressed as percentage PPI or reactivity to the prepulse-and-pulse
trials, was tested on withdrawal day 38 or 39 in Fischer (F) and Lewis
(L) rats pretreated with saline or amphetamine (N=12 per strain per
pretreatment). Percent PPI split by strain (a), by pretreatment (b), or
by strain and by pretreatment (c) for each prepulse and pulse;
reactivity to the prepulse-and-pulse trials split by strain (d), or by
strain and by pretreatment (e). Lewis rats showed increased PPI at the
two higher pulse intensities compared to Fischer rats, in both %PPI
and prepulse-and-pulse reactivity. All values are mean ± standard error
derived from the ANOVA. Condition “+0” represents the “no-
stimulus” condition in the test. Asterisks in (a) refer to statistical
significant difference between strains (p<0.05) based on restricted
analyses conducted at each level of pulse intensity
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compared (Fig. 5). As expected, a stronger reaction was
obtained with increasing prepulse intensity, but this
responsiveness was attenuated in the Fischer relative to
Lewis animals. Amphetamine pretreatment, on the other
hand, appeared to shift the response up across all prepulse
conditions (including no-stimulus condition). This impres-
sion was confirmed by 2×2×4 (strain × pretreatment ×
prepulse intensity) split-plot ANOVA across prepulse-alone
and no-stimulus trials, which yielded a highly significant
main effect of prepulse intensity [F(3, 132)=27.41, p<
0.001], and its interaction with strain [F(3, 132)=6.21, p<
0.001]. The main effect of pretreatment also achieved
statistical significance [F(1, 44)=4.08, p<0.05], but there
was no evidence that this effect depended on prepulse
intensity [pretreatment × prepulse intensity: F<1]. Pair-
wise comparisons between strains at successive prepulse
intensity showed that Fischer rats showed higher baseline
activity on no-stimulus trials [p<0.05], but weaker
response to the +18-dB prepulse stimulus [p<0.05], in
comparison to Lewis rats. Hence, there was some
indication that the relative reduction in PPI expression
revealed in the Fischer strain was accompanied by a
relatively weaker prepulse-elicited response to the pre-
pulse as seen in PPI disruption resulting from NMDA
receptor blockade (see, Yee et al. 2004).
Spontaneous object recognition
Familiarity judgment was evaluated using a spontaneous
object recognition memory test conducted in the open field
arena on withdrawal days 48 and 49. The sample phase
(object familiarization) and the choice phase (test of novelty
preference) were separately analyzed.
Sample phase Object exploration in the sample phase
across the 2 days of testing was compared across days,
instead of across delays (which was counterbalanced across
days) because the delay interval took place only after the
sample phase, and would not be expected to exert any
influence on sample phase behavior. To this end, a 2×2×
2×5 (strain × pretreatment × days × 1-min bins) split-plot
ANOVA of sample object exploration time (logarithmically
transformed) was conducted. As shown in Fig. 6a, a clear
habituation over the 5-min sample period was observed
[bins: F(4, 172)=21.32, p<0.001], and this habituation
effect was stronger in the Lewis than in the Fischer rats
[strain × bins: F(4, 172)=4.67, p<0.005; strain: F(1, 43)=
10.63, p<0.005]. Pair-wise comparisons between strains at
successive 1-min bins showed that object exploration time
was significantly less [p<0.05] in Lewis rats from bin 3
onwards (Fig. 6a).
A general reduction of object exploration was also
apparent across days [F(1, 43)=5.74; p<0.05; day 1=
12.40±0.16, day2=2.31±0.14], but this was not dissim-
ilar between strains. Amphetamine pretreatment also
resulted in a general reduction in sample exploration [F
(1, 43)=5.92; p<0.05; Fig. 6c], but this pretreatment
effect was not dependent on either days or rat strain.
Choice (test) phase Preferential exploration of the novel
(non-sampled) object was evaluated by a direct comparison
Fig. 5 Direct reaction in prepulse-alone trials. Reactivity to the
prepulse-alone trials observed in the PPI test after 38 or 39 days of
withdrawal in Fischer and Lewis rats pretreated with saline or
amphetamine (N=12 per strain per pretreatment). The direct reactivity
to prepulse-alone trials is presented split by strains (a), by pretreat-
ment (b), and by strain and by pretreatment (c). The Fischer rats
showed increased baseline reactivity in the no-stimulus trials, but a
weaker response to the +18-dB prepulse stimulus. Amphetamine
pretreatment resulted in decreased overall reactivity to prepulse-alone
trials. All values are mean ± standard error derived from the ANOVA.
Asterisks in (a) refer to statistically significant difference between
strains (p<0.05) based on pair-wise comparisons at successive
prepulse intensity conditions using the error variance associated with
the significant strain by prepulse intensity interaction taken from the
overall ANOVA; the asterisk in (b) denotes the overall main effect of
pretreatment (p<0.05)
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between time spent exploring the familiar and novel objects
by a 2×2×2×2 (strain × pretreatment × delays × novelty)
split-plot ANOVA of exploration time (logarithmically
transformed). Delay refers to a within-subject factor
counterbalanced across days, so the days factor was not
included in this analysis. As shown in Fig. 6d, preference
for the novel object was strengthened by amphetamine
pretreatment in the Fischer rats, but weakened by the same
treatment in Lewis rats. This contrast was already accom-
panied by a difference between strains in the saline-
pretreated animals: saline-pretreated Lewis rats exhibited a
stronger novel object preference than saline-pretreated
Fischer rats. Hence, amphetamine pretreatment effectively
reversed the existing strain difference in performance. This
interpretation of the data was confirmed by the critical
strain × pretreatment × novelty interaction that just reached
statistical significance [F(1, 44)=4.00, p=0.05]. This was
also accompanied by the presence of an overall novelty
effect [F(1, 44)=16.22; p<0.001]. There was, however, no
indication that the contrast in delay intervals (2 vs. 15 min)
affected performance: neither the main effect of delay nor
its interaction achieved statistical significance.
Spatial working memory test in the water maze
Spatial working memory function was evaluated using the
Morris water maze across withdrawal days 50 to 55. The
platform location was varied across test sessions, but
remained constant from trials 1 to 2 within a given session.
Working memory function was therefore effectively indexed
by improvement in escape from trials 1 to 2. There were a
total of ten sessions, with two sessions conducted per day
(separated by 4 h in-between sessions on the same day).
There was a systemic difference in swim speed between
Lewis and Fischer rats in this test [p<0.005], so we focused
on the statistical analysis of path length measure (logarith-
mic transformation of path length in meters) instead of
escape latency. However, analysis of escape latency yielded
similar impressions in terms of performance change as a
function of trials; and therefore the interpretation regarding
working memory function was essentially independent of
which of the two measures was examined.
Cued task All rats learned to escape from the water by
climbing onto the platform when its location was indicated
by the cue. There was an improvement in performance from
trials 1 to 2, as indicated by the presence of a highly
significant main effect of trials [F(1, 44)=24.99, p<0.001]
in a 2×2×2 (strain × pretreatment × trials) split-plot ANOVA
of path length (ln transformed path length in meters). The
mean log-transformed path lengths from trials 1 to 2 were
2.23±0.12 and 1.19±0.17, respectively.
Working memory As shown in Fig. 7, improvement in
performance as indicated by a reduction of escape path
length from trials 1 to 2 was apparent in all groups except the
saline-pretreated Fischer rats. However, the overall 2×2×5×
Fig. 6 Exploratorypair-wise comparisons between ‘new’ and ‘famil-
iar’ object exploration time based on the strain × pretreatment ×
novelty interaction (p<0.05)” were changed to “c” and “d”,
respectively. Please check if appropriate.?> behavior in the object
recognition task. Logarithmic transformation of the exploration time
in the object recognition test after 48 and 49 days of withdrawal in
Fischer and Lewis rats pretreated with saline or amphetamine (N=12
per strain per pretreatment) for each 1-min bin of the sample phase
split by strain (a) or by strain and by pretreatment (b), as total
exploration time during the sample phase split by pretreatment (c), and
for the test phase split by strain and by pretreatment (d). Fischer rats
failed to show a similar habituation to Lewis rats in the sample phase.
In addition, amphetamine pretreatment resulted in a slight but
significant decrease in exploration. In the test phase, amphetamine
pretreatment resulted in enhanced preference for the novel object in
Fischer rats, and inversely, a reduction of preference for the novel
object, in the Lewis rats. All values are mean ± standard error derived
from the ANOVA. Asterisks in (a) refer to statistical significant
difference between strains (p<0.05) based on pair-wise comparisons
at successive 1-min bins using the error variance associated with the
significant strain by bins interaction taken from the overall ANOVA;
the asterisk in (c) denotes the significant main effect of pretreatment
(p<0.05), and in (d) the significant pair-wise comparisons between
“new” and “familiar” object exploration time based on the strain ×
pretreatment × novelty interaction (p<0.05)
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2×2 (strain × pretreatment × days × sessions × trials) split-
plot ANOVA for swim path length only revealed a
significant main effect of strain [F(1, 44)=15.77, p<0.001]
and of trials [F(1, 44)=23.27, p<0.001], but not the critical
strain × pretreatment × trials interaction [F(1, 44)=1.89, p=
0.176] needed to support the specific impairment of working
memory function in saline-pretreated Fischer rats. However,
given the overall difference existing between strains, and the
a priori decision to examine the presence of a pretreatment
effect specific to each strain, supplementary restricted 2×5×
2×2 (pretreatment × days × sessions × trials) ANOVAs
confined to each rat strain were carried out. A significant
pretreatment by trials interaction [F(1, 22)=4.33, p<0.05]
was obtained in the Fischer rats, lending support to the
interpretation that amphetamine pretreatment affected work-
ing memory performance in this rat strain. This interpretation
is further supported by the presence of significant trials effect
only in the amphetamine-pretreated [F(1, 11)=5.54, p<0.05]
but not the saline-pretreated [F<1] Fischer rats. On the other
hand, the equivalent analysis restricted to the Lewis yielded
no indication of any effect of amphetamine pretreatment, but
only an overall effect of trials [F(1, 22)=22.88, p<0.001].
An identical pattern of results regarding working
memory function was obtained based on the statistical
analysis of escape latency (ln-transformed; data not shown).
Behavioral sensitization
The three phases of the experiment (baseline, saline, amphet-
amine) were conducted in the same activity boxes on
withdrawal days 57 (baseline) and 58 (saline and amphetamine
injections) and were separately analyzed and described below.
Baseline stage The baseline locomotor activity was mea-
sured during the last hour of the 18-h habituation period.
The animals expressed a stable low locomotor activity
throughout the 1-h observation. There was no evidence for
any significant strain difference, amphetamine pretreatment
or 20-min bins main effect in baseline locomotor activity
based on a 2×2×3 (strain × pretreatment × 20-min bins)
split-plot ANOVA (Fig. 8a). The interaction terms also did
not attain significance.
Fig. 7 Working memory in the Morris water maze. Logarithmic
transformation of the path length in the Morris water maze in meters
using the working memory protocol after 50–55 days of withdrawal in
Fischer and Lewis rats pretreated with saline or amphetamine (N=12
per strain per pretreatment). Performance split by strain and by
pretreatment for the five acquisition days. In the acquisition phase,
Lewis rats showed a good performance independent of the pretreat-
ment. Interestingly, in the Fischer rats, the saline group showed poor
performance, whereas the amphetamine-pretreated animals showed a
clear improvement between trials 1 and 2. All values are mean ±
standard error derived from the ANOVA
Fig. 8 Behavioral sensitization to an amphetamine challenge.
Locomotor activity measured following an initial 18-h habituation
period (only the last hour shown), a 1-h period following an injection
of saline, and a 3-h period following a challenge injection of 1 mg/kg
amphetamine on withdrawal day 59 presented by strain and by
treatment (a). The locomotor response to the amphetamine challenge
presented by strain (b) and by pretreatment (c). Fischer rats showed a
transient increased locomotor activity compared to Lewis rats until the
fourth 20-min bin (b). Amphetamine-pretreated rats exhibited
increased locomotor activity responses to the challenge during the
first seven 20-min bins (c). All values refer to means ± standard error
derived from the ANOVA. Asterisks in (b) and (c) refer to a statistical
difference between strains (p<0.05) and between pretreatments (p<
0.05), respectively, based on the appropriate pair-wise comparisons as
successive bins, using the error variance associated with the
significant strain by bins (b) and pretreatment by bins (c) interaction
in the overall ANOVA
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Saline stage Following saline injection, locomotor activity
was measured for a further hour. There was a transient
increase in locomotor activity (Fig. 8a), and these impres-
sions were supported by a 2×2×3 (strain × pretreatment ×
20-min bins) split-plot ANOVA of locomotor activity,
which yielded a significant main effect of bins [F(2, 24)=
23.03, p<0.001].
Amphetamine stage Following the amphetamine injection,
locomotor activity was measured for 3 h. All subjects
showed an increase in locomotor activity in response to the
amphetamine challenge that declined after 2 h (Fig. 8a).
Fischer rats showed an increased initial locomotor activity
and a higher peak response to the amphetamine challenge,
returning to comparable levels to Lewis after the fourth
20-min bin (Fig. 8b). The amphetamine-pretreated rats
showed an increased locomotor activity compared to the
saline-pretreated rats during the 2 h following the amphet-
amine challenge (Fig. 8c). These impressions were supported
by a 2×2×9 (strain × pretreatment × 20-min bins) split-plot
ANOVA of locomotor activity, which yielded a significant
main effect of pretreatment [F(1, 12)=12.75; p<0.005], of
bins (F(8, 96)=15.75; p<0.001], of pretreatment × bins
interaction [F(8, 96)=4.09; p<0.001], and of strain × bins
interaction [F(8, 96)=4.01; p<0.001]. Pair-wise compar-
isons between pretreatment and strain at each successive
bin yielded a significant pretreatment effect until the
seventh bin and a significant strain effect until the fourth
bin [p<0.05].
Discussion
The present study aims to evaluate the impact of a
sensitized dopamine system on cognitive performance in a
unique design that utilizes a well-characterized comparison
between Fischer and Lewis rats that markedly differ, among
other traits, in the tests of memory function selected here.
Under the non-sensitized (saline-pretreated) condition,
Fischer rats exhibited substantial performance deficiency
relative to Lewis rats in Pavlovian conditioning, spontane-
ous object recognition, and spatial working memory. In the
latter two tasks, in particular, non-sensitized Fischer rats
effectively failed to display any evidence of learning. These
observations are largely in line with previous comparative
studies of these two strains (Miserendino et al. 2003; Pryce
et al. 1999). Such severe cognitive impairment in the
Fischer rats contrasted sharply with their relatively mild
deficiency in sensorimotor gating and the transient reduc-
tion in spontaneous locomotor activity under unchallenged
condition observed in the open field test. Consideration of
these baseline strain differences is essential to the interpre-
tation of the behavioral cognitive effects of amphetamine
pretreatment.
Sensitivity and sensitization to systemic amphetamine
challenge
The presence of sensitization in the amphetamine-pretreated
animals was confirmed at the end of the experimental series
and was observed in both rat strains. In the absence of a
statistically significant strain by pretreatment interaction, it
is concluded that the functional sensitization achieved by
the present amphetamine pretreatment regime was not
dissimilar in the two strains. However, it should be noted
that Fischer rats were more responsive during their first
exposure to the drug. Given that the activity levels recorded
during the baseline and saline phase of the assessment were
highly comparable between strains, one suggestion would
be that the dopamine neurotransmitter system in Fischer
rats is more sensitive to the challenge of amphetamine
(Brodkin et al. 1998; George et al. 1991; Miserendino et al.
2003; Stohr et al. 1998b). In addition, there are notable
differences in mesolimbic dopamine axis reported between
Fischer and Lewis rats, including alterations to dopamine
physiology and metabolism in the ventral tegmental area
and nucleus accumbens (e.g., Beitner-Johnson et al. 1991,
1992, 1993; Camp et al. 1994; Flores et al. 1998; Guitart et
al. 1992, 1993; Strecker et al. 1995).
Taken together, there is ample evidence to suggest that
an intrinsic strain difference in the sensitivity of the
dopamine system existed prior to the sensitization treat-
ment. Such differences in mesolimbic dopamine function
are not only relevant to the divergent response between
strains to acute amphetamine challenge seen in our non-
sensitized animals (Di Chiara and Imperato 1988), but also
to the divergent effects subsequently seen during amphet-
amine withdrawal and during the behavioral assessments of
memory performance (see further discussion below).
The observed strain differences in the sensitivity to
amphetamine may also be partially mediated by differences
in the level in the hypothalamus–pituitary–adrenal system:
Lewis rats have been shown to exhibit a deficient neuroendo-
crine response to stress (Dhabhar et al. 1993; Rivest and Rivier
1994). As an example, stress- or drug-induced corticosterone
release is attenuated in Lewis compared to Fischer rats (Simar
et al. 1996). Cador et al. suggested that rats with a high
stress-induced corticosterone release show higher
amphetamine-induced locomotion and are more likely to
develop amphetamine self-administration (Cador et al. 1993).
Relevance beyond psychotic symptoms?
The critical evaluation here concerns whether amphetamine-
induced sensitization produces dissimilar effects between
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strains. Our behavioral analyses have identified effects that
are common to both strains, unique to one strain only, or act in
incongruent directions between strains. The mnemonic effects
of amphetamine-induced sensitization are among such strain-
dependent effects. In comparison to their respective non-
sensitized controls, sensitized Fischer rats exhibited notable
improvement in object recognition as well as in spatial
working memory. On the other hand, sensitized Lewis rats
performed poorly relative to non-sensitized Lewis controls in
the object recognition test. In contrast, Pavlovian conditioning
was entirely insensitive to amphetamine pretreatment, even
though the two strains also differed substantially in baseline
performance, which was consistent with existing reports (e.g.,
Pryce et al. 1999). Two possible explanations for the
increased freezing levels of the Lewis rats as compared to
the Fischer rats were: (a) The Lewis strain is known to have
poor acquisition of two way active avoidance (Katzev and
Mills 1974; Stohr et al. 1998a), which is due to increased
freezing levels; and (b) lower pain threshold in the Lewis
strain rather than any difference in general anxiety response
(as shown here) (Stohr et al. 1998a).
Altogether, these findings suggest that neither genetic
background nor baseline performance difference alone could
sufficiently account for the present data. Firstly, amphet-
amine pretreatment was not preferentially effective in one
strain rather than in the other. Secondly, although baseline
performance was generally lower in the Fischer rats,
amphetamine pretreatment did not indiscriminately elevate
performance in all cases: neither Pavlovian conditioning nor
PPI expression in Fischer rats was responsive to amphet-
amine pretreatment. Similarly, amphetamine pretreatment
did not indiscriminately lower performance in Lewis rats.
From a different perspective, the experimental outcomes,
therefore, do not readily suggest any direct resemblance to
the cognitive deficits characteristic of schizophrenia. Instead,
there was evidence that a sensitized dopamine system might
facilitate working memory function—at least in the Fischer
rats. Should one therefore conclude that the amphetamine
sensitization model of schizophrenia bears little relevance to
the cognitive symptoms of the disease?
Prepulse inhibition
We first consider the outcome of the PPI experiment
because Geyer (2006) proposes that “although PPI cannot
be considered to be a cognitive process per se, [its]
abnormalities … may be predictive of, or lead to, complex
cognitive deficits”. The PPI paradigm employed here has
been shown to be sensitive to systemic apomorphine or
dizocilpine (MK-801) treatment in rats (Pothuizen et al.
2006) and was able to detect the difference existing
between Fischer and Lewis rats, yet it failed to reveal any
effect of amphetamine pretreatment on PPI expression. This
is somewhat surprising given that the efficacy of the present
amphetamine pretreatment regime to produce PPI deficit
has been previously demonstrated by Fletcher and col-
leagues although in another rat strain, namely Sprague–
Dawley rats (Tenn et al. 2003, 2005). This discrepancy may
likely reflect a strain-dependent sensitivity to this specific
amphetamine treatment regime. Hence, at least in terms of
PPI, an active regime identified in one strain of rats (even
an outbred strain) may not readily generalize to other
strains. We have previously demonstrated that a similar
escalating amphetamine regime was without any effect on
PPI expression in Wistar rats (Murphy et al. 2001; Peleg-
Raibstein et al. 2006a; Russig et al. 2002, 2003, 2005). This
apparent lack of consistency across rat strains specific to
PPI may not be too surprising given that considerable
divergence between strains also exists following acute
pharmacological treatments (Swerdlow et al. 1998; Varty
and Geyer 1998). Moreover, the present null results should
not be taken as evidence that PPI expression in Fischer and
Lewis rats is relatively insensitive to amphetamine-induced
sensitization because they may respond to another schedule,
as we have previously demonstrated in Wistar animals
(Peleg-Raibstein et al. 2006a, b, 2008; Russig et al. 2005).
It should be emphasized that such strain- and regime-
dependent effects on PPI are always reported against a clear
presence of behavioral sensitization effect to a subsequent
acute amphetamine challenge. Hence, additional experi-
ments with other amphetamine pretreatment schedules and
the inclusion of multiple strains would be warranted to fully
interpret the relevance of the current null results in PPI.
At present, it would be prudent not to infer that our PPI
results refute the hypothesis that sensitization of the
dopamine system is without any effect on sensorimotor
gating or related cognitive functions. Instead of relying on
the proposed potential of PPI to index cognitive function,
another obvious approach to examining the face validity of
the amphetamine withdrawal model for schizophrenia
cognitive deficiency is surely to employ tests that directly
tax mnemonic functions.
Inconsistent mnemonic effects
Intriguingly, amphetamine withdrawal led to divergent
effects on mnemonic functions between Fischer and Lewis
rats. It improved performance in the working memory water
maze test and object recognition in Fischer rats, but
impaired object recognition memory in Lewis rats without
affecting water maze performance.
In recreational users of methamphetamine and amphet-
amine, abstinence is associated with working memory
deficit and right dorsolateral prefrontal cortex (PFC)
activation (Ersche et al. 2006; McCann 2008). This may
reflect a similar mechanism responsible for the poor
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working memory performance observed in schizophrenia,
which is believed to stem from a deficiency in dorsolateral
PFC dopaminergic function (Davis et al. 1991; Weinberger
1987). Studies in rats and primates have suggested that
amphetamine withdrawal is associated with multiple sig-
nificant changes in PFC dopaminergic function: reduced
responsiveness to dopamine and D1 receptor agonist
(Peterson et al. 2000, 2006), reduced dopamine turnover
(Castner et al. 2005), and (compensatory) elevated PFC
dopamine release during aversive classical conditioning
(Peleg-Raibstein et al. 2008).
The modulation of working memory performance by
PFC dopaminergic activity, however, is likely to follow an
inverted U-shape function (see Fig. 9a): Deficits are
reported when PFC dopaminergic signaling is either
excessively enhanced or reduced, such that efficiency in
performance falls below the optimal level (for a review, see
Williams and Castner 2006).
Could the strain-dependent outcomes reflect known
differences in dopaminergic functions between the two rat
strains? Several lines of evidence suggest that the meso-
limbic dopaminergic system may be more active in Fischer
than Lewis rats. Fischer rats show a stronger expression of
tyrosine hydroxylase and baseline dopamine metabolites in
the nucleus accumbens compared with Lewis rats (Beitner-
Johnson et al. 1991; Camp et al. 1994; Guitart et al. 1992;
Ortiz et al. 1995). Indeed, we also showed here that (saline-
pretreated) Fischer rats were more responsive to the first
exposure to amphetamine, and that PFC dopaminergic
activation in response to stress is higher in Fischer than in
Lewis rats (Lindley et al. 1999). This was sufficiently
excessive to impair water maze learning in the saline-
pretreated Fischer rats, given the stressful nature of the
water maze paradigm (see also Dalla et al. 2008; Del Arco
and Mora 2001). Against this background, amphetamine
withdrawal is expected to lead to a reduction (leftward
shift) in prefrontal dopaminergic activity in both rat strains
as depicted in Fig. 9a. It is therefore conceivable that this
reduction returned the Fischer rats to a more favorable level
of dopaminergic activity that benefited performance, while
it was insufficient to significantly impair performance in
Lewis rats because the reduction did not exceed the lower
margin of the optimal range.
With a slight modification, this scheme may also account
for the bidirectional effects of amphetamine withdrawal
between strains observed in object recognition memory
(Fig. 9b), although it is the perirhinal cortex that is more
critically involved in object recognition (Steckler et al.
1998), and the contribution of the PFC cortex may only be
limited to specific forms of object-in-place memory (Barker
et al. 2007; Hannesson et al. 2004). However, the ascending
dopaminergic inputs from the ventral tegmental area (a
critical dopaminergic substrate of amphetamine sensitiza-
tion: for a review, see Kalivas and Stewart 1991) also
project to the perirhinal cortex and adjoining temporal
structures (Deacon et al. 1983; McIntyre et al. 1996) and
therefore may also assume a modulatory function over
object recognition memory and/or novelty detection (e.g.,
Lisman and Grace 2005; McNab et al. 2009). This
dopaminergic modulation may similarly follow an inverted
Fig. 9 Impact of the different between-subject factors on the
prefrontal dopaminergic function and the consequent influence on
working memory performance. a The inverted U-shape curve of
correspondence between prefrontal dopaminergic activity and memory
performance in the water maze task. Lewis rats are known to present
decreased dopaminergic activity compared to Fischer rats, and
therefore have a shift to the left. Similarly, amphetamine sensitization
has been shown to lead to a decrease in prefrontal dopaminergic
activity and to a hypothetical decrease of the integrated mesolimbic
dopaminergic projections on the perirhinal cortex, and consequently,
sensitized animals are also shifted to the left of the curve. The four
experimental groups, both Fischer and Lewis rats that were pretreated
with either amphetamine or saline, were placed accordingly on the
curve. b Similar inverted U-shape curve fitting for all four treatment
groups, but for the relationship between mesolimbic dopaminergic
levels and performance in the object recognition paradigm. The
difference in terms of spread of the experimental group on the inverted
U-shape curve originates from changes of modulatory structures and
the increased dopaminergic activity resulting from the more stressful
procedure in the water maze. Given the existence of multiple memory
systems (as exemplified by the contrast between working memory and
object recognition here), the possibility that each is associated with a
distinct optimal dopaminergic modulation is an interesting and testable
hypothesis that certainly warrants further investigation
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U-shaped profile. Given the intrinsic baseline difference in
dopaminergic activity between Fisher and Lewis rats, it is
also conceivable that a similar leftward shift in mesolimbic
dopaminergic activity induced by amphetamine withdrawal
improved performance in Fischer rats (by optimizing
dopaminergic modulation) but impaired performance in
Lewis rats (due to excessive reduction beyond the optimal
range; Fig. 9b).
This scheme that takes into account baseline differences
in dopaminergic activity, and the inverted U-shaped profile
of dopaminergic modulation of cognitive processes may
further accommodate data obtained in other rat strains,
providing a possible parsimonious account for divergent
outcomes. Furthermore, it may account for the relative
efficacy of different amphetamine treatment regimes and
their respective efficacy between strains in modifying
cognitive functions.
Beyond strain-dependent validity
The present study has yielded only limited evidence that the
amphetamine pretreatment schedule employed here might
produce pronounced schizophrenia-like cognitive deficien-
cy in either Fischer or Lewis rats. However, a conclusion
that amphetamine withdrawal may not be a useful model
beyond schizophrenia psychotic symptoms may be prema-
ture. We obtained significant effects on memory functions,
albeit the direction of the effects clearly depended on rat
strains. The unexpected findings of performance improve-
ment seen in Fischer rats may be less surprising when one
takes into account the unique inverted U-shaped profile of
dopaminergic modulation over cognitive functions. More-
over, this is in line with some indications that acute
amphetamine administration can improve cognitive func-
tioning in medicated schizophrenia patients (Barch and
Carter 2005; Goldberg et al. 1991; Kirrane et al. 2000).
Hence, there is certainly value in further examining the
neural basis of amphetamine withdrawal—not only in terms
of its face validity (in producing schizophrenia-like cogni-
tive deficits) but also its construct validity in relation to
modeling the disease mechanisms as well as potential
therapeutic avenues. In this respect, the use of multiple
inbred rat strains may be particularly useful.
Here, we showed that the choice of strains can be as
important as the precise amphetamine treatment schedule
employed in determining the ultimate impact on cognition.
There has been considerable debate between laboratories as
to the relative efficacy of different amphetamine withdrawal
schedules. The present study exemplifies that although this
schedule has been shown to be capable in inducing some
cognitive deficits in outbred Sprague–Dawley rats (Fletcher
et al. 2005, 2007; Tenn et al. 2005), this finding may not be
readily generalized to other rat strains. By choosing inbred
rats, one reduces the strain variability and genetic hetero-
geneity against a reproducible and definable difference in
genetic background. When divergent effects emerge as
shown here, the results can be further examined in terms of
genetic propensity or vulnerability to the development of
schizophrenia-like psychopathology (under a specific envi-
ronmental challenge as defined, for example, by an
amphetamine treatment schedule). Such an approach would
enhance the construct validity of the model and lead
eventually to the specification of animal models with more
robust face validity as well as predictive validity.
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